Evidence map›Paper›PMID 20044515›Full record

ArticleCirculation research2010

Intracellular Ca2+ silences L-type Ca2+ channels in mesenteric veins: mechanism of venous smooth muscle resistance to calcium channel blockers.

Keshari M Thakali, Sujay V Kharade, Swapnil K Sonkusare, Sung W Rhee, Joseph R Stimers, Nancy J Rusch

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Circulation research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2021
    Pooled it
  2. 17β-estradiol reduces CaPharmacology research & perspectives · 2017
    Article
  3. Origins of variation in conducted vasomotor responses.Pflugers Archiv : European journal of physiology · 2015
    Article
  4. Ca(2+) and ion channels in hypoxia-mediated pulmonary hypertension.International journal of clinical and experimental pathology · 2015
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. New mechanisms of pulmonary arterial hypertension: role of Ca²⁺ signaling.American journal of physiology. Heart and circulatory physiology · 2012
    Review
  14. Article
  15. Review
  16. Large-conductance Ca2+-activated K+ channel beta1-subunit knockout mice are not hypertensive.American journal of physiology. Heart and circulatory physiology · 2011
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Keshari M ThakaliDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Little Rock, AR 72205, USA. KMThakali@uams.edu
Sujay V Kharade
Swapnil K Sonkusare
Sung W Rhee
Joseph R Stimers
Nancy J Rusch
University of Vermont · US

Funding

Vascular Calcium Channel Expression in HypertensionR01HL064806 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI RUSCH, NANCY J · 2000 to 2012
$3.4M
L-type calcium channels are silent during depolarization of venous smooth muscleF32HL095284 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI THAKALI, KESHARI · 2009 to 2011
$146k
NHLBI NIH HHS F32 HL095284NHLBI NIH HHS R01 HL064806NHLBI NIH HHS R01 HL064806-09
6 · The paper itself

Abstract

rationaleCalcium channel blockers (CCBs) exert their antihypertensive effect by reducing cardiac afterload but not preload, suggesting that Ca(2+) influx through L-type Ca(2+) channels (LTCC) mediates arterial but not venous tone.

objectiveThe object of this study was to resolve the mechanism of venous resistance to CCBs. METHODS AND

resultsWe compared the sensitivity of depolarization (KCl)-induced constriction of rat small mesenteric arteries (MAs) and veins (MVs) to the dilator effect of CCBs. Initial findings confirmed that nifedipine progressively dilated depolarization-induced constrictions in MAs but not MVs. However, Western blots showed a similar expression of the alpha(1C) pore-forming subunit of the LTCC in both vessels. Patch-clamp studies revealed a similar density of whole-cell Ca(2+) channel current between single smooth muscle cells (SMCs) of MAs and MVs. Based on these findings, we hypothesized that LTCCs are expressed but "silenced" by intracellular Ca(2+) in venous SMCs. After depletion of intracellular Ca(2+) stores by the SERCA pump inhibitor thapsigargin, depolarization-induced constrictions in MVs were blocked 80% by nifedipine suggesting restoration of Ca(2+) influx through LTCCs. Similarly, KCl-induced constrictions were sensitive to block by nifedipine after depletion of intracellular Ca(2+) stores by caffeine, ryanodine, or 2-aminoethoxydiphenyl borate. Cell-attached patch recordings of unitary LTCC currents confirmed rare channel openings during depolarization of venous compared to arterial SMCs, but chelating intracellular Ca(2+) significantly increased the open-state probability of venous LTCCs.

conclusionsWe report that intracellular Ca(2+) inactivates LTCCs in venous SMCs to confer venous resistance to CCB-induced dilation, a fundamental drug property that was previously unexplained.

Indexed as

Drug ResistanceAnimalsBlotting, WesternCalciumCalcium Channel BlockersCalcium Channels, L-TypeChelating AgentsDose-Response Relationship, DrugEnzyme InhibitorsMaleMembrane PotentialsMesenteric ArteriesMesenteric VeinsMuscle, Smooth, VascularNifedipinePatch-Clamp TechniquesCalciumCalcium Channel BlockersCalcium Channels, L-TypeChelating AgentsEnzyme InhibitorsL-type calcium channel alpha(1C)NifedipinePotassium ChlorideSarcoplasmic Reticulum Calcium-Transporting ATPasesVasoconstrictor AgentsVasodilator Agents

Identifiers

PMID20044515
PMCPMC2855128
OpenAlexW2039679841

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.